A gene based model using nasopharyngeal carcinoma biomarkers AURKA and BUB1 accurately predicts survival and demonstrates strong clinical utility in patient risk assessment.
Yusuf Roohani, PhD, machine learning group lead at the Arc Institute, is among a team of researchers training artificial intelligence (AI) models with transcriptome data to predict how cell gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results